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Abstract
Background: There are safety concerns regarding widespread consumption of phytosterol and phytostanol
supplemented food products. The aim of this study was to determine, in the absence of excess dietary salt, the
individual effects of excess accumulation of dietary phytosterols and phytostanols on blood pressure in Wistar
Kyoto (WKY) inbred rats that have a mutation in the Abcg5 gene and thus over absorb phytosterols and
phytostanols.
Methods: Thirty 35-day old male WKY inbred rats (10/group) were fed a control diet or a diet containing
phytosterols or phytostanols (2.0 g/kg diet) for 5 weeks. The sterol composition of the diets, plasma and tissues
were analysed by gas chromatography. Blood pressure was measured by the tail cuff method. mRNA levels of
several renal blood pressure regulatory genes were measured by real-time quantitative PCR.
Results: Compared to the control diet, the phytosterol diet resulted in 3- to 4-fold increases in the levels of
phytosterols in plasma, red blood cells, liver, aorta and kidney of WKY inbred rats (P < 0.05). The phytostanol diet
dramatically increased (> 9-fold) the levels of phytostanols in plasma, red blood cells, liver, aorta and kidney of
these rats (P < 0.05). The phytosterol diet decreased cholesterol levels by 40%, 31%, and 19% in liver, aorta and
kidney, respectively (P < 0.05). The phytostanol diet decreased cholesterol levels by 15%, 16%, 20% and 14% in
plasma, liver, aorta and kidney, respectively (P < 0.05). The phytostanol diet also decreased phytosterol levels by
29% to 54% in plasma and tissues (P < 0.05). Both the phytosterol and phytostanol diets produced significant
decreases in the ratios of cholesterol to phytosterols and phytostanols in plasma, red blood cells, liver, aorta and
kidney. Rats that consumed the phytosterol or phytostanol diets displayed significant increases in systolic and
diastolic blood pressure compared to rats that consumed the control diet (P < 0.05). The phytosterol diet increased
renal angiotensinogen mRNA levels of these rats.
Conclusion: These data suggest that excessive accumulation of dietary phytosterols and phytostanols in plasma
and tissues may contribute to the increased blood pressure in WKY inbred rats in the absence of excess dietary salt.
Therefore, even though phytosterols and phytostanols lower cholesterol levels, prospective clinical studies testing
the net beneficial effects of dietary phytosterols and phytostanols on cardiovascular events for subgroups of
individuals that have an increased incorporation of these substances are needed.
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Elevated blood levels of total cholesterol and low-density
lipoprotein cholesterol (LDL-C) are established risk fac-
tors for the development of cardiovascular disease in
humans [1]. Phytosterols and phytostanols are lipid
compounds structurally similar to cholesterol. Intake of
phytosterols and/or phytostanols at the level of 1.5-3.0
g/day has been documented to reduce blood LDL-C by
10% [2,3], which would decrease coronary heart disease
risk by 27%, if the LDL-C reduction was sustained for 5
years [4]. The efficacy and safety of phytosterol- and
phytostanol-enriched food products has been reviewed
by several regulatory agencies, and the sale of phytos-
terol- and phytostanol-enriched food products have
been allowed as a means to reduce blood cholesterol
levels by many European countries [5], the United States
[6], and Australia and New Zealand [7]. In Canada,
health claims for phytosterol and phytostanol food sup-
plementation are currently under review [8].
No unexpected side effects have been reported since
phytosterol- and phytostanol-enriched food products
have been introduced into the food supply [9]. However,
studies indicating a pro-atherogenic effect of phytosterols
and phytostanols have been published, as outlined below.
First, phytosterolemic patients over-absorb and accumu-
late phytosterols and phytostanols, and develop prema-
ture coronary artery disease [10,11]. Second, the use of
phytosterol or phytostanol-enriched food products was
found to elevate phytosterol and phytostanol levels in
serum in free-living populations [12,13] and in healthy
subjects [14], and epidemiological studies have demon-
strated that elevated serum levels of phytosterols and
phytostanols are associated with increased atherosclerotic
cardiovascular disease [15-1 8 ] .T h i r d ,p h y t o s t e r o l sa n d
phytostanols have been detected in atherosclerotic
lesions from a phytosterolemic patient who died suddenly
of a myocardial infarction [10], and also from patients
with aortic stenosis [19]. Fourth, phytosterol and phytos-
tanol supplementation increased plasma phytosterol and
phytostanol levels, impaired endothelial function and
increased cerebral lesion size in wild-type mice [19].
Fifth, elevated systolic blood pressure was observed in
salt-loaded spontaneously hypertensive-stroke prone
(SHRSP), spontaneously hypertensive (SHR) and Wistar
Kyoto (WKY) rats fed a high phytosterol diet [20-24], as
well as in a phytosterolemic patient [10].
Although phytosterolemia (also known as sitosterole-
mia) is a rare autosomal recessive disorder, the preva-
lence of this disorder is likely underestimated due to
misdiagnosis as hyperlipidemia since the standard col-
orimetric and enzymatic methods for the detection
of cholesterol do not distinguish cholesterol from
phytosterols and phytostanols. In addition, although
homozygosity for a mutation that causes phytosterole-
mia is rare, heterozygosity is much more common
(1/1100 individuals) [3]. These individuals usually have
2-fold higher levels of serum phytosterols compared to
healthy people [25,26]. In a study of 595 hypercholester-
olemic subjects in the United States, 3.5% of the subjects
had elevated levels of serum phytosterols with acceler-
ated atherosclerosis [15]. These results suggest that a
substantial proportion of the population that would be
recommended to consume phytosterol and phytostanol
supplemented foods could be made worse by these pro-
ducts. Therefore, although most healthy individuals do
not absorb high levels of phytosterols and phytostanols,
it is important to try to understand the mechanisms of
action of phytosterols and phytostanols for subgroups of
individuals that have an increased incorporation of these
substances. Also, since phytosterol and phytostanol sup-
plemented foods are being marketed for individuals with
high serum cholesterol, a risk factor for heart disease, it
is important to assess the mechanisms of action of these
products for individuals predisposed to coronary heart
disease, stroke and atherosclerosis.
Our previous data showed that dietary phytosterols
and phytostanols increased the incorporation of phytos-
terols and phytostanols in plasma and tissues in diabetic
[27] and salt-loaded SHRSP rats [28-30] as well as ele-
vated diastolic blood pressure, accelerated the onset of
stroke and reduced the life span in salt-loaded SHRSP
rats [28-31]. However, salt-loading is known to acceler-
ate the development of hypertension and hypertensive-
related conditions [32]. The presence of extra salt may
contribute to or mask effects of dietary phytosterols and
phytostanols. In the present study our objective was to
isolate and identify the individual effects of increased
intake of phytosterols and phytostanols on sterol accu-
mulation, blood pressure and the expression of renal
blood pressure regulatory genes from any potential con-
founding effects of salt-loading. WKY inbred rats were
used because this rat strain is usually used as a ‘normo-
tensive’ model compared to its ‘descendant’ SHRSP rat
strain [33]. Also, we have determined that, similar to
phytosterolemic patients, WKY inbred rats have a muta-
tion in the Abcg5 gene that results in increased tissue
incorporation of phytosterols and phytostanols [34].
Therefore, we can use this model to investigate the
health effects and mechanisms of action that result from
increased absorption of dietary phytosterols and
phytostanols.
Materials and methods
Phytosterols and phytostanols preparation
Phytosterols were prepared from canola oil deodorizer
distillate as described previously by us [29]. Deodorizer
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ble oils. It is a complex mixture of free fatty acids, phy-
tosterols and their esters, tocopherol esters, and mono-,
di- and triacylglycerols. In a typical preparation, 1 kg of
canola oil deodorizer distillate (supplied by CanAmera
Foods, Altona, Manitoba, Canada) containing 19.9%
sterols was saponified, acidified and methylated. The
non-saponifiable fraction containing free phytosterols
was recovered and recrystalized using heptane. This pro-
duced 124 g of 100% pure phytosterols. The purity of
the phytosterol product was determined by gas liquid
chromatography (GC) and thin-layer chromatography
analysis (TLC) [29]. The phytosterol product contained
22.0% brassicasterol, 31.9% campesterol, 43.2% beta-
sitosterol and 2.9% other phytosterols.
A portion of the recrystalized phytosterol product was
converted to phytostanols via catalytic hydrogenation as
described previously by us [31] at the pilot plant facility
of the POS Plant Corporation (Saskatoon, SK, Canada).
The final phytostanol product was 100% pure as deter-
mined by GC and TLC, and contained 54.7% campesta-
nol and 44.8% sitostanol.
Diet preparation
Three diets were prepared according to our previous
publication [31] based on the AIN-93G recommenda-
tions for rodent diets [35]. The final total phytosterol
and phytostanol content of the diets was 0.2, 2.1 and 1.9
g/kg in the control diet, phytosterol diet and phytostanol
diet, respectively. These levels are the same as the levels
we used in our previous study [31]. These dietary levels
of phytosterols and phytostanols were used because our
previous studies demonstrated that 2.0 g/kg diet of phy-
tosterols and phytostanols significantly accelerated the
o n s e to fs t r o k ea n dr e d u c e dt h el i f es p a no fS H R S Pr a t s
[28-30]. These dietary levels of phytosterols and phytos-
tanols are similar to the amounts suggested for choles-
terol lowering in humans on a dietary fat basis [3]. For
example, consumption of 2.0 g per day of dietary phy-
tosterols or phytostanols in an individual that consumes
100 g of fat per day (average fat intake) represents 2.0%
of that person’s fat intake. Our rats were also fed 2.0 g
of phytosterols or phytostanols in a diet that contained
100 g of fat (soybean oil) per kg of diet which represents
2.0% of the rat’s dietary fat intake.
Animals
WKY inbred rats were obtained from Charles River
Laboratories (Kingston, NY, USA). 35-day old male
WKY inbred rats were randomly assigned to one of
three diet groups (n = 10/group, Table 1). They had free
access to drinking water. After 5 weeks on the test diets,
12 h food-deprived rats were euthanised via exsanguina-
tion from the abdominal aorta while under 3%
isoflurane anaesthesia. Blood was collected in hepari-
nised polystyrene tubes. Plasma and red blood cells
were isolated as described previously [28]. Liver, aorta
and kidneys were removed, frozen immediately in liquid
nitrogen and stored at -80°C. The animal protocol was
approved by the Institutional Animal Care Committee
at Health Canada.
Analyses of sterols
The sterol composition of the diets, plasma, red blood
cells, liver, aorta, and kidney were analysed by gas chro-
matography as described previously [29,30].
Measurement of blood pressure
Blood pressure was measured at the beginning, middle
and end (week 1, 3 and 5) of the feeding phase of the
study by the tail cuff method using a II TC Model 31
Blood Pressure Apparatus (II TC INC/Life Science
Instruments, Woodland Hills, CA, USA) as described
previously [31]. Briefly, the blood pressure apparatus
was stored in a separate, warmer room (26-27°C). The
pressure channels were calibrated every day and the
chamber was kept at 29-30°C. Rats were trained on the
apparatus every day for 1 week prior to the experiment.
Rats were transferred to the blood pressure room 30
min before handling to allow them to gradually get used
to the heat. Each rat was placed in the chamber for 5
min prior to starting the measurements, allowing rats to
acclimatize. The same investigator monitored the com-
puter screen and the animal in order to detect artifacts
such as animal distress or movement. The systolic blood
pressure and the mean blood pressure were measured
by the same investigator every time. The diastolic blood
pressure was calculated by the equation: diastolic = (3 ×
mean - systolic)/2 as per the manufacturer’si n s t r u c -
tions. The blood pressure of each rat at each measuring
point was obtained as an average of three readings. The
coefficient of variation (CV) is from 1.47% to 6.24%.
RNA isolation and real-time quantitative RT-PCR
Procedures described previously were followed [31].
Briefly, total RNA was extracted from each kidney sam-
ple and purified. Total RNA (1 μg) was reverse-tran-
scribed to synthesize cDNA with Retroscript Kit
(Ambion, Austin, TX, USA). Real-time quantitative PCR
was performed on a Mx4000 Multiplex Quantitative
PCR System using the Brilliant SYBR Green QPCR Core
Reagent Kit (Stratagene, La Jolla, CA, USA) or Taqman
Gene Expression Assay (Applied Biosystems, Foster city,
CA, USA) as described previously [31].
Statistical analysis
Data are presented as the means ± standard deviation
(SD). Statistical analyses were performed using Statistica
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sis of variance (ANOVA) followed by post-hoc Duncan’s
multiple range test was used to determine the diet
effects and compare differences among group means.
A l ld a t aw e r ee v a l u a t e df o re q u a l i t yo fv a r i a n c ep r i o rt o
statistical analysis. Variables with skewed distribution
were logarithm-transformed. A non-parametric Kruskal-
Wallis test followed by Wilcoxon rank sum tests was
employed if the data failed to satisfy equality of variance.
Differences were considered significant when P ≤ 0.05.
Results
Body weight, food intake, water consumption and
histopathologic findings
Body weight of the animals increased steadily during the
5 week feeding phase of the study. There were no effects
of diet on body weight gain, food efficiency and total
water consumption (Table 2). No significant lesions
were found in liver and kidney in paraffin-embedded
hematoxylin and eosin stained slides. A cross-section of
thoracic and abdominal aorta was examined and no sig-
nificant lesions were seen (data not shown).
Sterol composition in plasma, red blood cells, liver, aorta,
and kidney
In comparison to the control diet, the phytosterol diet
increased phytosterol incorporation in plasma (4.1-fold,
P < 0.05), red blood cells (3-fold, P < 0.05), liver (2.9-
fold, P < 0.05), aorta (3.1-fold, P < 0.05) and kidney
(4.1-fold, P <0 . 0 5 )i nW K Yinbred rats (Table 3). The
phytostanol diet dramatically increased phytostanol
incorporation in plasma (145-fold, P < 0.05), red blood
cells (9.2-fold, P < 0.05), liver (31.6-fold, P < 0.05), aorta
(95-fold, P < 0.05) and kidney (141-fold, P <0 . 0 5 )i n
these rats. The phytostanol diet decreased phytosterol
incorporation in plasma (54%, P < 0.05), red blood
cells (35%, P < 0.05), liver (29%, P < 0.05), aorta (38%,
P < 0.05) and kidney (46%, P < 0.05).
Table 1 Composition of test diets
1
Control diet Phytosterol diet Phytostanol diet
Ingredient g/kg diet
Vitamin free casein 222.0 222.0 222.0
Soybean oil 100.0 100.0 100.0
Phytosterols
2 — 2.0 —
Phytostanols
3 —— 2.0
Cornstarch 477.5 475.5 475.5
Granulated sugar 100.0 100.0 100.0
Cellulose (alphacel) 50.0 50.0 50.0
Miscellaneous
4 50.5 50.5 50.5
Sterol composition
Cholesterol 0.0 0.0 0.0
Total phytosterols
5 0.2 2.1 0.2
Total phytostanols
6 0.0 0.0 1.7
Total phytosterols and phytostanols 0.2 2.1 1.9
1Based on the AIN-93G diet (American Institute of Nutrition, 1993). All ingredients, except phytosterols and phytostanols, were purchased from Harlan Teklad
(Madison, WI).
2Phytosterols isolated from canola oil deodorizer distillate (CanAmera Foods, Altona, MB, Canada).
3Phytostanols were hydrogenated from phytosterols (POS Pilot Plant Corporation, Saskatoon, SK, Canada).
493G-MX Mineral mix (35.0 g/kg), 93-VX Vitamin mix (10.0 g/kg), L-cystine (3.0 g/kg), choline bitartrate (2.5 g/kg) and tert-butylhydroquinone (0.014 g/kg).
5Total phytosterols include campesterol, beta-sitosterol, stigmasterol, brassicasterol, and delta 5,24- stigmastadienol.
6Total phytostanols include campestanol and sitostanol.
Table 2 Growth, food and water intake of the rats in the absence of salt-loading
Control diet (n = 10) Phytosterol diet (n = 10) Phytostanol diet (n = 10) P value (one-way ANOVA)
Initial body wt (g) 131.5 ± 15.2 133.9 ± 13.5 129.2 ± 12.7 0.7513
Body wt at week 5 (g) 265.9 ± 26.3 267.3 ± 16.0 258.5 ± 19.5 0.6084
Weight gain (g/5 weeks) 134.4 ± 13.0 133.5 ± 5.8 129.4 ± 8.8 0.4728
Total food intake (g) 539.6 ± 55.6 541.2 ± 46.6 519.0 ± 33.7 0.4959
Food efficiency (g gain/kg intake) 249.3 ± 8.6 247.9 ± 18.1 249.4 ± 10.3 0.9590
Total water consumption (g) 1010.9 ± 197.8 963.7 ± 82.5 1045.1 ± 147.9 0.4872*
Values are presented as means ± SD. * Nonparametric (Kruskal-Wallis) test
Chen et al. Nutrition & Metabolism 2010, 7:11
http://www.nutritionandmetabolism.com/content/7/1/11
Page 4 of 9In comparison to the control diet, the phytosterol diet
decreased cholesterol levels in liver (40%, P < 0.05),
aorta (31%, P < 0.05) and kidney (19%, P < 0.05) of
these rats. The phytostanol diet also decreased choles-
terol levels in plasma (15%, P < 0.05), liver (16%, P <
0.05), aorta (20%, P < 0.05) and kidney (14%, P < 0.05).
The effects of phytosterols and phytostanols on choles-
terol lowering in red blood cells did not reach statistical
significance (overall P = 0.0789, Table 3).
Compared to the control diet, the phytosterol diet
decreased total sterol levels in liver (P <0 . 0 5 ) ,a o r t a
(P <0 . 0 5 )a n dk i d n e y( P < 0.05), but increased total
sterols in plasma (P < 0.05) of these rats. The phytosta-
nol diet also decreased total sterol levels in aorta (P <
0.05) and kidney (P < 0.05). However, the phytosterol
diet resulted in the lowest ratio of cholesterol to total
phytosterols and total phytostanols in plasma, red blood
cells, liver, aorta and kidney (P < 0.05, Table 3). The
phytostanol diet also decreased this ratio in plasma and
all tissues tested (P < 0.05).
Blood pressure
There were no differences in the initial systolic and
diastolic blood pressure among groups (P = 0.5857 and P
= 0.5373, respectively, Table 4). After consuming the diets
for 5 weeks, the WKY inbred rats fed the phytosterol and
phytostanol diets had significantly higher systolic (P =
0.0067) and diastolic (P = 0.0001) blood pressure as well
as greater increases in systolic (P =0 . 0 3 3 3 )a n dd i a s t o l i c
(P = 0.0021) blood pressure, when compared to the rats
Table 3 Sterol levels in plasma (mg/100 ml) and tissues (mg/100 g) of rats in the absence of salt-loading
Tissue Sterol Control diet
(n = 10)
Phytosterol diet
(n = 10)
Phytostanol diet
(n = 10)
P value (one-way ANOVA)
Plasma
Total phytosterols 8.2 ± 1.3
b 33.6 ± 4.9
c 3.8 ± 0.7
a 0.0001
Total phytostanols 0.1 ± 0.1
a 0.1 ± 0.1
a 14.5 ± 2.2
b 0.0001*
Cholesterol 80.9 ± 5.8
b 75.5 ± 10.3
ab 68.8 ± 6.9
a 0.0076
Total sterols 89.1 ± 6.6
a 109.1 ± 14.1
b 87.1 ± 9.0
a 0.0001
Cholesterol/phytosterols & phytostanols 10.0 ± 1.3
c 2.3 ± 0.3
a 3.8 ± 0.4
b 0.0001
Red blood cells
Total phytosterols 10.0 ± 2.6
b 29.7 ± 7.4
c 6.5 ± 0.7
a 0.0001
Total phytostanols 1.0 ± 0.4
a 0.8 ± 0.4
a 9.2 ± 0.9
b 0.0001
Cholesterol 101.9 ± 26.1 81.9 ± 20.8 85.2 ± 10.8 0.0789
Total sterols 112.9 ± 28.5 112.5 ± 28.3 100.9 ± 11.3 0.4611
Cholesterol/phytosterols & phytostanols 9.4 ± 1.5
c 2.7 ± 0.2
a 5.5 ± 0.8
b 0.0001
Liver
Total phytosterols 19.0 ± 5.3
b 54.8 ± 8.1
c 13.5 ± 1.5
a 0.0001
Total phytostanols 0.7 ± 0.2
a 0.6 ± 0.3
a 22.1 ± 2.7
b 0.0001
Cholesterol 223.5 ± 46.1
c 134.3 ± 18.1
a 187.9 ± 23.7
b 0.0001
Total sterols 243.3 ± 51.1
b 189.8 ± 24.6
a 223.6 ± 27.0
b 0.0141
Cholesterol/phytosterols & phytostanols 11.5 ± 1.1
c 2.4 ± 0.2
a 5.3 ± 0.4
b 0.0001
Aorta
Total phytosterols 8.7 ± 2.9
b 26.6 ± 5.7
c 5.4 ± 0.9
a 0.0001
Total phytostanols 0.1 ± 0.1
a 0.3 ± 0.7
a 9.5 ± 1.8
b 0.0001*
Cholesterol 125.5 ± 32.8
c 86.5 ± 20.4
a 100.7 ± 14.0
ab 0.0038
Total sterols 134.1 ± 35.4
b 113.4 ± 25.3
a 115.5 ± 13.2
a 0.1705
Cholesterol/phytosterols & phytostanols 14.7 ± 2.1
c 3.2 ± 0.5
a 7.0 ± 2.0
b 0.0001
Kidney
Total phytosterols 9.8 ± 1.8
b 40.2 ± 3.8
c 5.3 ± 0.8
a 0.0001
Total phytostanols 0.1 ± 0.1
a 0.1 ± 0.1
a 14.1 ± 1.2
b 0.0001*
Cholesterol 320.6 ± 10.4
b 258.6 ± 28.6
a 276.2 ± 46.6
a 0.0006
Total sterols 330.4 ± 10.9
b 298.8 ± 27.8
a 295.7 ± 47.3
a 0.0438
Cholesterol/phytosterols & phytostanols 33.6 ± 5.2
c 6.5 ± 1.1
a 14.2 ± 2.4
b 0.0001
Values are presented as means ± SD. * Nonparametric (Kruskal-Wallis) test
a,b,c means in a row not sharing a superscript letter are significantly different (P < 0.05, Duncan’s test or Wilcoxon rank sum tests).
Total phytosterols include campesterol, beta-sitosterol, stigmasterol, brassicasterol, and delta 5,24-stigmastadienol.
Total phytostanols include campestanol and sitostanol.
Total sterols include cholesterol + total phytosterols + total phytostanols.
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increase in diastolic blood pressure (P < 0.05) compared to
the phytosterol diet.
Renal mRNA expression of genes involved in blood
pressure regulation
In comparison to the control diet, the phytosterol diet sig-
nificantly increased mRNA levels of renal angiotensinogen
in WKY inbred rats (P = 0.0339, Table 5), but did not
change renal mRNA levels of renin, angiotensin I convert-
ing enzyme 1, 2 (Ace1, Ace2), angiotensin II receptor type
1a (Agtr1a), nitric oxide synthase 1, 3 (Nos1, Nos3),
cyclooxygenase 2, Spondin 1 and THUMP domain contain-
ing 1 (P > 0.05). There were no effects of phytostanols on
mRNA expression of all genes measured (P > 0.05).
Discussion
High blood pressure is a serious condition that can lead to
coronary heart disease, stroke, kidney failure, and other
health problems [36]. Effects of phytosterols and phytosta-
nols on blood pressure remain controversial. In human
studies, consumption of a dietary portfolio (plant sterols,
soybean protein, viscous fibres and almonds) for 1 year
significantly reduced blood pressure in 66 hyperlipidemic
subjects [37]. Intake of a product containing sitostanol and
campestanol for 4 weeks slightly decreased systolic blood
pressure in 100 healthy men [38]. However, elevated systo-
lic blood pressure was observed in a phytosterolemic
patient [10]. In animal studies, in the presence of 1% salt-
loading, our previous study demonstrated that, phytosterol
or phytostanol supplemented diets (2.0 g/kg diet) induced
a significant increase in diastolic blood pressure in SHRSP
rats [31]. Similarly, Naito et al. [22-24] showed that a diet
containing 10% rapeseed oil (0.71 g total phytosterols/kg
diet) induced higher systolic blood pressure than a diet
containing soybean oil (0.29 g total phytosterols/kg diet)
in SHRSP, SHR and WKY rats and thus thought that the
higher content of phytosterols in rapeseed oil was related
to the increased blood pressure. A diet containing soybean
oil fortified with phytosterols (4.5 g/kg diet) for 24 days
was also reported to elevate systolic blood pressure in
SHRSP rats, but there were no significant differences on
systolic blood pressure among diets containing 10% rape-
seed oil, 10% soybean oil, and 10% soybean oil supplemen-
ted with 0.6 g total phytosterols/kg diet [20]. A study by
Chen et al. [39] demonstrated that consumption of a sitos-
terol diet (0.3 g/kg diet) for 6 weeks did not increase blood
pressure in wild-type, heterozygous and homozygous (a
Table 4 Systolic and diastolic blood pressure (BP) of the rats in the absence of salt-loading
Control diet
(n = 10)
Phytosterol diet
(n = 10)
Phytostanol diet
(n = 10)
P value (one-way ANOVA)
Initial systolic BP (mmHg) 113.7 ± 7.3 110.9 ± 10.7 115.3 ± 8.8 0.5857
Systolic BP at week 5 (mmHg) 127.0 ± 6.2
a# 136.0 ± 8.2
b# 138.6 ± 7.4
b# 0.0067
Change in systolic BP (mmHg/5 weeks) 13.3 ± 8.5
a 25.1 ± 12.0
b 23.4 ± 9.1
b 0.0333
Initial diastolic BP (mmHg) 78.0 ± 3.9 81.0 ± 7.8 79.9 ± 6.1 0.5373
Diastolic BP at week 5 (mmHg) 82.6 ± 4.0
a# 89.7 ± 5.8
b# 95.2 ± 5.8
c# 0.0001
Change in diastolic BP (mmHg/5 weeks) 4.6 ± 3.6
a 8.7 ± 5.8
b 15.2 ± 7.1
c 0.0021
Values are presented as means ± SD.
a,b,c means in a row not sharing a superscript letter are significantly different (P < 0.05, Duncan’s test).
# means significantly different from initial measurement of systolic or diastolic blood pressure, respectively (week 5 vs initial, P < 0.05, t-test).
Table 5 Kidney gene expression of the rats in the absence of salt-loading
Control diet (n = 10) Phytosterol diet (n = 10) Phytostanol diet (n = 10) P value (one-way
ANOVA)
Angiotensinogen 1.00 ± 0.12
a 1.20 ± 0.28
b 0.95 ± 0.17
a 0.0339
Renin 1.00 ± 0.17 1.05 ± 0.17 1.17 ± 0.37 0.3597
Angiotensin I converting enzyme (Ace) 1 1.00 ± 0.13 1.05 ± 0.08 1.11 ± 0.34 0.5948
Ace 2 1.00 ± 0.15 1.03 ± 0.22 0.99 ± 0.21 0.8884
Angiotensin II receptor (Agtr) 1a 1.00 ± 0.08 0.94 ± 0.11 0.93 ± 0.10 0.3131
Nitric oxide synthase (Nos) 1 1.00 ± 0.36 0.84 ± 0.20 1.04 ± 0.29 0.3170
Nos 3 1.00 ± 0.11 1.00 ± 0.21 1.07 ± 0.21 0.6882
Cyclooxygenase 2 1.00 ± 0.26 1.09 ± 0.31 1.09 ± 0.34 0.7696
Spondin 1 1.00 ± 0.07 1.10 ± 0.17 1.01 ± 0.10 0.1988
THUMP domain 1 1.00 ± 0.16 0.93 ± 0.20 1.10 ± 0.23 0.2103
Values are presented as means ± SD.
a,b means in a row not sharing a superscript letter are significantly different (P < 0.05, Duncan’s test).
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of salt-loading, our present study found that dietary phy-
tosterols or phytostanols (2.0 g/kg diet) significantly
increased systolic and diastolic blood pressure in WKY
inbred rats (Table 4). To our knowledge, this was the first
study to investigate, in the absence of salt-loading, the
effects of dietary phytosterols and phytostanols on blood
pressure in rodent models. Our results were consistent
with those reported by Naito et al. [21] who demonstrated
that, in the absence of salt-loading, a diet containing 10%
rapeseed oil for 4 weeks induced a higher systolic blood
pressure in SHRSP rats compared to a diet containing 10%
soybean oil. Taken together, our previous and present
results suggest that increased intake of phytosterols or
phytostanols may exacerbate hypertension in both hyper-
tensive and normotensive rat models that over absorb
phytosterols and phytostanols in the presence or absence
of salt.
In order to elucidate the molecular mechanism(s) by
which intake of phytosterols and phytostanols increased
blood pressure in this rat model, the expression of sev-
eral renal genes known to be involved in the renin-
angiotensin-aldosterone system, nitric oxide, and
cyclooxygenase-derived prostanoid pathways were inves-
tigated (Table 5). Spondin 1 and THUMP domain con-
taining 1 were also measured because they were recently
identified as candidate hypertension genes [40,41]. Our
present study demonstrated that, in the absence of salt-
loading, the phytosterol diet slightly increased the
mRNA expression of angiotensinogen (1.2-fold, P < 0.05,
Table 5). There were no effects of phytosterols and phy-
tostanols on the mRNA expression of renin, angiotensin
I converting enzyme (Ace1) 1, Ace2, angiotensin II recep-
tor 1a (Agtr1a), nitric oxide synthases (Nos) 1, Nos3,
Cyclooxygenase 2, Spondin 1 and Thump domain 1 (P >
0.05). These results suggest that Nos, Cyclooxygenase 2,
Spondin 1 and Thump domain 1 pathways do not play a
critical role in the blood pressure regulation caused by
the intake of phytosterols and phytostanols in WKY
inbred rats. Also, the phytostanol diet increased blood
pressure but did not change the mRNA levels of renal
angiotensinogen. Therefore, the renin-angiotensin-aldos-
terone system may not play a leading role in the hyper-
tensive responses caused by phytosterol and phytostanol
diets in the absence of salt-loading in WKY inbred rats.
Currently there are no data indicating that consump-
tion of phytosterol and phytostanol-enriched foods alters
cardiovascular events, but epidemiological studies indi-
cated a controversial association of phytosterols and
phytostanols with cardiovascular risk. For example, the
results from a cohort study in 1242 subjects older than
65 years in the Netherlands showed that plasma levels
of phytosterols were significantly lower in patients with
coronary heart disease [42]. A prospective nested case-
control study consisting of 373 cases and 758 controls
in the United Kingdom indicated that there was no
adverse relationship between plasma physiological levels
of phytosterols and coronary heart disease risk in appar-
ently healthy individuals [43]. The study from 2542 sub-
jects aged 30 to 67 years in the United States showed
no significant difference in plasma sitosterol and cam-
pesterol levels between the individuals having a positive
and a negative family history of CHD [44]. However,
studies in 595 subjects with hypercholesterolemia [15],
in 48 postmenopausal women [16], in 53 patients under-
going coronary artery bypass graft surgery [17] and in
159 men that suffered a myocardial infarction in the
Prospective Cardiovascular Munster study [18] suggest
an association of elevated levels of phytosterols and phy-
tostanols with an increased cardiovascular disease risk.
In the present study dietary phytosterols and phytosta-
nols (2.0 g/kg diet) were found, in the absence of salt-
loading, to significantly increase systolic and diastolic
blood pressure (P < 0.05, Table 4), to increase phytos-
terol and phytostanol accumulation in plasma, red blood
cells, liver, aorta and kidney (P < 0.05), and to decrease
cholesterol levels in liver, aorta, and kidney as well as
plasma (only by phytostanols) (P <0 . 0 5 )( T a b l e3 ) .
These results suggest that, even though phytosterols and
phytostanols lower cholesterol levels, their excessive
accumulation in plasma and tissues may increase blood
pressure thereby causing their net beneficial effects on
cardiovascular events to remain questionable.
Our previous study indicated that a deficiency of
membrane cholesterol due to phytosterol intake
increases cell membrane rigidity, which might be a fac-
tor contributing to the shortened life span of SHRSP
rats [29]. Hamano et al. [45] also reported that a diet
containing cholesterol (10 g/kg diet) delayed the onset
of stroke and prolonged the life span of SHRSP rats,
whereas diets with no added cholesterol greatly shor-
tened post-stroke survival. In the present study supple-
mentation of phytosterols and phytostanols produced
significant decreases in the ratios of cholesterol to phy-
tosterols and phytostanols in plasma, red blood cells,
liver, aorta and kidney (Table 3) and increased blood
pressure (Table 4) in WKY inbred rats. Therefore, the
increased blood pressure caused by phytosterols and
phytostanols in WKY inbred r a t sm a yb ed u et o
increased cell membrane rigidity. Other studies, in WKY
rats in the presence of salt and in SHRSP rats in the
absence of salt, have proposed that enhanced membrane
activity of Na+, K+-ATPase by phytosterols in rapeseed
oil may play a role in elevated blood pressure [21,22].
Other mechanisms, such as endothelin and natriuretic
peptides [46], have not been excluded from playing a
role in hypertension caused by phytosterols and phytos-
tanols in WKY inbred rats in this study and could be
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isms of action of dietary phytosterols and phytostanols
responsible for the absorption and accumulation of cho-
lesterol, phytosterols and phytostanols have been pre-
viously discussed in our recently published paper [47].
Interestingly, it is generally speculated that phytosta-
nol supplementation may be safer than phytosterol sup-
plementation because the absorption of phytostanols
(1-2%) is less than that of phytosterols (4-13%) [48] and
the plasma levels of phytostanols are much less than
that of phytosterols in humans after consumption of
similar levels of either substance [49]. However, in our
present study, the phytostanol diet resulted in a signifi-
cant increase in diastolic blood pressure compared to
the phytosterol diet (P < 0.05, Table 4). This result is
consistent with our previous study in which SHRSP rats
fed phytostanol supplemented margarine had a slightly
lower survival rate than rats fed phytosterol supplemen-
ted margarine [28].
Conclusion
Our study demonstrated for the first time that, in the
absence of salt-loading, dietary phytosterols and phytos-
tanols (2.0 g/kg diet) significantly increase systolic and
diastolic blood pressure, and decrease the ratios of cho-
lesterol to phytosterols and phytostanols in plasma, red
blood cells, liver, aorta and kidney in WKY inbred rats.
The renin-angiotensin-aldosterone system, prostanoids
system, nitric oxide system, Spondin 1 and THUMP
domain containing 1 do not appear to contribute signifi-
cantly to the increased blood pressure. Increased cell
membrane rigidity caused by a decreased ratio of choles-
terol to phytosterols and phytostanols may contribute to
the increased blood pressure. The net beneficial effect of
phytosterols and phytostanols on cardiovascular events
for individuals predisposed to over absorption of phytos-
terols and phytostanols requires further investigation.
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